VitaNova Life Sciences (VNOV) FCF Margin (2017 - 2026)
VitaNova Life Sciences (VNOV) reported FCF Margin of 12.74% for Q1 2026, down 8048.0% on a YoY basis from 0.16% in Q1 2025, and down 125.58% quarter-over-quarter from 49.79% in Q4 2025.
VitaNova Life Sciences (VNOV) FCF Margin (2017 - 2026) Analysis & Trends
VitaNova Life Sciences has reported FCF Margin for 7 years, with the latest figure at 12.74% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 8048.0% year-over-year to 12.74%; the trailing twelve-month figure through Jan 2026 stood at 27.09% (up 6519.0% YoY), and the FY2025 full-year result was 7.24%, up 7311.0% from the prior year.
- FCF Margin for Q1 2026 stood at 12.74%, down from 49.79% in the prior quarter.
- The five-year high for FCF Margin was 253.91% in Q3 2025, with the low at 576.85% in Q1 2024.
- Historically, FCF Margin has averaged 64.22% across 5 years, with a median of 3.0% in 2024.
- Annual changes were most pronounced in 2023 — FCF Margin slumped 29924 bps — and 2025, when it jumped 71853 bps.
- VitaNova Life Sciences' FCF Margin stood at 53.06% in 2022, then sank by 244 bps to 76.17% in 2023, then surged by 104 bps to 3.0% in 2024, then soared by 1560 bps to 49.79% in 2025, then sank by 126 bps to 12.74% in 2026.
- The last three FCF Margin figures came in at 12.74% (Q1 2026), 49.79% (Q4 2025), and 253.91% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 3.48% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.50% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 2.75% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -3.62% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -19.45% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -18.96% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 1.06% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -6.02% |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | -12.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -12.74% |
| Oct 31, 2025 | 49.79% |
| Jul 31, 2025 | 253.91% |
| Apr 30, 2025 | 24.53% |
| Jan 31, 2025 | 67.75% |
| Oct 31, 2024 | 3.00% |
| Jul 31, 2024 | -464.62% |
| Apr 30, 2024 | -35.11% |
| Jan 31, 2024 | -576.85% |
| Apr 30, 2023 | -76.17% |
| Jan 31, 2023 | -281.77% |
| Oct 31, 2022 | 53.06% |
| Jul 31, 2022 | 45.21% |
| Apr 30, 2022 | -30.74% |
| Jan 31, 2022 | 17.47% |
| Oct 31, 2021 | 43.54% |
| Jul 31, 2017 | 34.09% |